These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7266464)

  • 1. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
    Zahniser NR; Heidenreich KA; Molinoff PB
    Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
    Roberts PJ; Davis A
    Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
    [No Abstract]   [Full Text] [Related]  

  • 4. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
    List SJ; Wreggett KA; Seeman P
    J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
    Mulder TB; Grol CJ; Dijkstra D; Horn AS
    Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
    Bradbury AJ; Costall B; Naylor RJ
    J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
    Davis A; Poat JA; Woodruff GN
    Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of [3H]ADTN to rat striatal membranes.
    Templeton WW; Woodruff GN
    Biochem Pharmacol; 1982 Apr; 31(8):1629-32. PubMed ID: 6124259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
    Roberts PJ; Woodruff GN; Poat JA
    Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
    [No Abstract]   [Full Text] [Related]  

  • 10. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons.
    Hoffmann IS; Naylor RJ; Cubeddu LX
    J Pharmacol Exp Ther; 1980 Nov; 215(2):486-93. PubMed ID: 7441511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor binding regulated by guanine nucleotides.
    Creese I; Usdin TB; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):69-76. PubMed ID: 481426
    [No Abstract]   [Full Text] [Related]  

  • 15. [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum.
    Schoemaker H; Langer SZ
    Eur J Pharmacol; 1986 May; 124(3):371-3. PubMed ID: 2942413
    [No Abstract]   [Full Text] [Related]  

  • 16. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
    Hirschhorn ID; Makman MH
    Eur J Pharmacol; 1982 Sep; 83(1-2):61-7. PubMed ID: 7128701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN) into rat brain synaptosomes [proceedings].
    Davis A; Roberts PJ; Woodruff GN
    Br J Pharmacol; 1977 Nov; 61(3):478P-479P. PubMed ID: 588829
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in (3H)-ADTN binding to microsomal and synaptic membrane fractions from rat striata following kainic acid lesions.
    Davis A; Woodruff GN; Poat JA; Freedman SB
    Biochem Pharmacol; 1980 Jun; 29(12):1645-8. PubMed ID: 7406893
    [No Abstract]   [Full Text] [Related]  

  • 20. The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.
    Tedesco JL; Seeman P; McDermed JD
    Mol Pharmacol; 1979 Sep; 16(2):369-81. PubMed ID: 514252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.